hotspot -WSS

hotspot

author：leisure time 2025-09-30 00:48:30 - browse：37377

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Crowdfunding for unproven stem cell procedures spreads misinformation

focus

WSS

CDC recommends rationing of RSV shot due to shortages

What affirmative action's end means to a medical student

CDC recommends rationing of RSV shot due to shortages

Emergency medicine has repudiated 'excited delirium.' Now what?

Senate panel to vote on hospitals, PBMs, prisoner care

FDA has safety concerns on CRISPR

focus

hotspot

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Skip the lead apron during X

As demand for Covid shots wanes, Moderna seeks its next success

STAT wants to know your pick for a great summer read or listen

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: What happened with Sarepta's Duchenne data

Hepatitis C has a cure — but many Americans still lack access to it

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

knowledge

Lupron, used to halt puberty in children, may cause lasting health problems

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Telehealth options flood the market as retailers push virtual care

Readout Newsletter: XBI biotech index, Akero Therapeutics

The biotech scorecard for Q3: 15 stock

Undocumented workers face uncertainty as immigration law takes effect in Florida

hotspot

focus

focus

focus